Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer’s Prevention Trial: A global Perspective from the API Generation Program

BACKGROUND: Alzheimer’s disease (AD) prevention trials require a large outreach and screening funnel to identify cognitively unimpaired adults who meet the study’s inclusion criteria, such as certain clinical or demographic criteria, genetic risk factors, and/or biomarker evidence of the disease. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, T., Duff, L., Riviere, M.-E., Tariot, P.N., Doak, K., Smith, M., Borowsky, B., Lopez, C. Lopez, Arratia, P.C., Liu, F., Scholten, I., Gordon, D., Arbuckle, J., Graf, A., Quinn, M., Ricart, J., Langbaum, J.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426731/
https://www.ncbi.nlm.nih.gov/pubmed/37357285
http://dx.doi.org/10.14283/jpad.2023.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426731/
https://www.ncbi.nlm.nih.gov/pubmed/37357285
http://dx.doi.org/10.14283/jpad.2023.27

Ejemplares similares